Who
Michael Alexander Smith
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Insmed.
In numbers
- Trades disclosed
- 128
- Buys
- 0
- Sells
- 41
- Bought
- $0
- Sold
- $42.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Jul 2021
- Last trade
- 22 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jun 2026filed 24 Jun 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $173K1,806 at $95.82 | filing |
| 22 Jun 2026filed 24 Jun 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $173K1,806 at $95.82 | filing |
| 3 Jun 2026filed 5 Jun 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $221K2,159 at $102.27 | filing |
| 3 Jun 2026filed 5 Jun 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $221K2,159 at $102.27 | filing |
| 22 May 2026filed 22 May 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $667K6,149 at $108.47 | filing |
| 22 May 2026filed 22 May 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $667K6,149 at $108.47 | filing |
| 13 May 2026filed 15 May 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $477K4,109 at $116.18 | filing |
| 13 May 2026filed 15 May 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $477K4,109 at $116.18 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $96K5,649 at $17.07 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $390K13,989 at $27.89 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $3.0M19,638 at $150.98 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,649 at $0.00 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,989 at $0.00 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,649 at $0.00 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM Insmedoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,989 at $0.00 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $96K5,649 at $17.07 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $390K13,989 at $27.89 | filing |
| 30 Mar 2026filed 31 Mar 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $3.0M19,638 at $150.98 | filing |
| 24 Feb 2026filed 25 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code M | $346K20,248 at $17.07 | filing |
| 24 Feb 2026filed 25 Feb 2026 | INSM InsmedBiotechnology | SEC FORM 4 Sold | $747K4,852 at $153.93 | filing |
News
No headline names them, or the companies they trade most, lately.